Press Release

<< Back
Jan 09, 2018
Boston Heart Diagnostics Creates Patient/Provider Ecosystem with Progress

Provider of personalized health diagnostics and programs accelerates application development by 40 percent with Progress technologies

BEDFORD, Mass.--(BUSINESS WIRE)-- Progress (NASDAQ: PRGS), the leading provider of application development and deployment technologies, today announced that Boston Heart Diagnostics, a provider of personalized patient health diagnostics and lifestyle programs, has chosen Progress® Kendo UI®, Progress® Telerik® DevCraft™ and Progress® Corticon® products to power the development of its state of the art patient and healthcare provider portals.

The patient and healthcare provider portals are an ecosystem where laboratory test results, personalized diagnostics reports, and customized lifestyle reports with information from patients and dietitians are aggregated, tracked and shared with the providers within a secure environment that protects the patient's information. Boston Heart Diagnostics' solutions can enhance patient engagement and education with explanations of test results and treatment considerations in language and imagery patients can understand and make actionable toward a healthier lifestyle.

Boston Heart Diagnostics chose the Progress suite of solutions for its robust functionality, flexibility and an extremely intuitive end user experience. The Progress Corticon business rules engine helps to create a Life Plan tailored to each patient based on their test results, health history and food preferences provided on the Boston Heart patient portal.

Boston Heart Diagnostics uses Progress Kendo UI, an extremely robust JavaScript UI component library for building high quality, high-performance responsive web apps, and Progress Telerik DevCraft, the leading .NET UI toolkit, to deliver rich user experience in their patient and healthcare provider portals. Delivering quality web UI while reducing development time by 40 percent.

"With Progress, we can now help people to improve their health every day in a personalized manner, where, when and how they want it," said Shalom Keynan, Director of Application Development, Boston Heart Diagnostics. "Progress has given us the opportunity to create a digital experience that will improve the health of our patients."

"User experience has quickly become the new battleground for competitive advantage. If companies aren't delivering the best experience in their applications, they will get lost in the crowd," said Faris Sweis, SVP and GM, Developer Tooling, Progress. "Our application development and deployment tools significantly increase development productivity and accelerate time to market, but more importantly, we help enterprises like Boston Heart Diagnostics build beautiful applications that customers want to use."

To learn more about the story of Boston Heart, click here or view additional customer success stories at

Additional Resources

About Progress
Progress (NASDAQ: PRGS) offers the leading platform for developing and deploying mission-critical business applications. Progress empowers enterprises and ISVs to build and deliver cognitive-first applications that harness big data to derive business insights and competitive advantage. Progress offers leading technologies for easily building powerful user interfaces across any type of device, a reliable, scalable and secure backend platform to deploy modern applications, leading data connectivity to all sources and award-winning predictive analytics that brings the power of machine learning to any organization. Over 1,700 independent software vendors, 100,000 enterprise customers and 2 million developers rely on Progress to power their applications. Learn about Progress at or +1-800-477-6473.

Progress, Telerik, Kendo UI and Corticon are trademarks or registered trademarks of Progress Software Corporation or one of its subsidiaries or affiliates in the US and other countries. Any other trademarks contained herein are the property of their respective owners.

Kim Baker, 1 888-365-2779

Source: Progress

News Provided by Acquire Media